🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase I trial to study the effectiveness of interleukin-12, paclitaxel, and...
Status
Completed
Location
Ohio State University Medical Center
Start Date
2001-11
Trial ID
NCT00028535
Treatments Being Tested
Adverse cutaneous drug reactions are undesirable and typically unanticipate...
Status
Unknown
Location
Multiple Locations
Start Date
2017-07
Trial ID
NCT03166241
The purpose of this study is to determine whether the combination of interl...
Status
Completed
Location
Oncology Research Associates, Pllc D/B/A
Start Date
2011-12
Trial ID
NCT01489059
The purpose of this study is to determine whether the combination of the 2 ...
Status
Completed
Location
Oncology Research Associates, Pllc D/B/A
Start Date
2012-06
Trial ID
NCT01629758
Treatments Being Tested
This phase II trial studies how well tocilizumab works in treating chronic ...
Status
Withdrawn
Location
Mayo Clinic Hospital
Start Date
2016-02
Trial ID
NCT02174263
Treatments Being Tested
This phase 1, first-in-human study uses a BOIN design to assess the safety ...
Status
Unknown
Location
Taipei Medical University -Shuang Ho Hospital
Start Date
2022-02-28
Trial ID
NCT05296772
The purpose of the study is to evaluate whether recombinant IL-21 used in c...
Status
Completed
Location
University of California, Los Angeles
Start Date
2006-06
Trial ID
NCT00347971
Treatments Being Tested
RATIONALE: Interleukin-21 may stimulate white blood cells, including natura...
Status
Completed
Location
Cross Cancer Institute
Start Date
2007-12-13
Trial ID
NCT00514085
This phase II trial studies the best dose and effect of tocilizumab in comb...
Status
Active Not Recruiting
Location
Kaiser Permanente-Anaheim
Start Date
2022-03-11
Trial ID
NCT04729959
This phase I trial finds out the best dose and side effects of venetoclax a...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2022-10-19
Trial ID
NCT05391750
Treatments Being Tested